Thus, we confirmed that FIG-ROS serves as a potent oncoprotein in ICC and that ROS1-6290 and FIG-363 segments may serve as therapeutic targets for ICC harboring ROS1 fusion proteins. The gene discussed is ROS1; the disease is intrahepatic cholangiocarcinoma.